Invention Grant
- Patent Title: Naphthyridinone derivatives for the treatment of a disease or disorder
-
Application No.: US18057505Application Date: 2022-11-21
-
Publication No.: US12084442B2Publication Date: 2024-09-10
- Inventor: Atwood Kim Cheung , Donglei Liu , Stefan Peukert , Heng Ge , Yu Gai , Xingjuan Chang
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Timothy P. O'Dea
- Main IPC: A61K45/06
- IPC: A61K45/06 ; C07D471/04
Abstract:
The invention relates to a compound of formula (I):
or a pharmaceutically acceptable salt thereof, wherein A, R1 and R3 are as described herein, as well as compositions and methods of using such compounds.
or a pharmaceutically acceptable salt thereof, wherein A, R1 and R3 are as described herein, as well as compositions and methods of using such compounds.
Public/Granted literature
- US20230203032A1 NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER Public/Granted day:2023-06-29
Information query
